News
The latest science and news from the Institute.
-
Dr Jess Taylor vows to Race for Life at Home
1st May 2020
Dr Jessica Taylor is inspiring people to Race for Life at home and carry on the fight against the disease in these unprecedented times.
Find out more -
Prof Kevin Brindle elected as a Fellow of the Royal Society
29th April 2020
Prof Kevin Brindle has joined 50 exceptional scientists from around the world to be elected as a Fellow of the Royal Society.
Find out more -
Dr Nitzan Rosenfeld receives EACR Cancer Researcher Award
25th February 2020
Senior Group Leader Dr Nitzan Rosenfeld has been announced as the winner of the 2020 Pezcoller Foundation – EACR Cancer Researcher Award.
Find out more -
Zooming in on breast cancer reveals how mutations shape the tumour landscape
17th February 2020
Scientists have created one of the most detailed maps of breast cancer ever achieved, revealing how genetic changes shape the physical tumour landscape.
Find out more -
Unprecedented exploration generates most comprehensive map of cancer genomes charted to date
5th February 2020
An international team has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment.
Find out more -
Magnetised molecules used to monitor breast cancer
20th January 2020
A new type of scan that involves magnetising molecules allows doctors to see in real-time which regions of a breast tumour are active.
Find out more -
Single-cell analysis of the earliest cell fate decisions in development
11th December 2019
Researchers have provided the first single-cell epigenomic analysis of gastrulation, a crucial process in early embryo development.
Find out more -
Azeria Therapeutics announces £32 million Series B financing
19th November 2019
Azeria Therapeutics (Azeria), a newly formed pioneer factor drug discovery company founded by Group Leader Prof Jason Carroll, today announced a £32 million Series B financing.
Find out more -
Blocking a survival mechanism could tackle melanoma treatment resistance
14th November 2019
The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells.
Find out more